PPT-MM-005: A Phase 1, Multicenter, Open-Label, Dose-Escalation Study

to Determine the Maximum Tolerated Dose for the Combination of Pomalidomide Bortezomib and Low Dose Dexamethasone in Patients with Relapsed or RelapsedRefractory

btz pom dose patients pom btz patients dose abstract 2012 proc dex richardson cohort 727 ash response combination phase

Presentation Embed Code

<iframe width="560" height="315" src="https://www.docslides.com/embed/779547" frameborder="0" allowfullscreen></iframe>

Download Presentation

Download Presentation The PPT/PDF document "MM-005: A Phase 1, Multicenter, Open-Lab..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.